Brief: PLx Pharma Posts Q4 Loss Per Share $0.87
12/03/2021 12:44
March 12 (Reuters) - PLx Pharma Inc PLXP.O :
* . REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS AND
PROVIDES
BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.87
* U.S. COMMERCIAL LAUNCH OF VAZALORE PLANNED FOR Q3 2021
* PLX PHARMA - AS OF DEC 31, 2020, CO HAD CASH AND CASH
EQUIVALENTS OF $22.4 MILLION
* CO RECOGNIZED NO REVENUE FOR Q4 OF 2020 COMPARED TO
$24,000 FOR
Q4 OF 2019
Source text for Eikon: ID:nGNX5rdlCg
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice